Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Simona Pogliani"'
Autor:
Daniela Lisini, Sara Nava, Simona Frigerio, Simona Pogliani, Guido Maronati, Angela Marcianti, Valentina Coccè, Gianpietro Bondiolotti, Loredana Cavicchini, Francesca Paino, Francesco Petrella, Giulio Alessandri, Eugenio A. Parati, Augusto Pessina
Publikováno v:
Pharmaceutics, Vol 12, Iss 5, p 411 (2020)
Mesenchymal stromal cells (MSCs) prepared as advanced therapies medicinal products (ATMPs) have been widely used for the treatment of different diseases. The latest developments concern the possibility to use MSCs as carrier of molecules, including c
Externí odkaz:
https://doaj.org/article/ca4a207a0b884c0aa0509828ed64cfc9
Autor:
Sara Nava, Daniela Lisini, Simona Frigerio, Simona Pogliani, Serena Pellegatta, Laura Gatti, Gaetano Finocchiaro, Anna Bersano, Eugenio Agostino Parati
Publikováno v:
Pharmaceutics, Vol 12, Iss 3, p 215 (2020)
Dendritic cells (DC) are the most potent antigen-presenting cells, strongly inducers of T cell-mediated immune responses and, as such, broadly used as vaccine adjuvant in experimental clinical settings. DC are widely generated from human monocytes fo
Externí odkaz:
https://doaj.org/article/673bf26dde334825b20098d77ad28e94
Autor:
Sara Nava, Marta Dossena, Simona Pogliani, Serena Pellegatta, Carlo Antozzi, Fulvio Baggi, Cinzia Gellera, Bianca Pollo, Eugenio A Parati, Gaetano Finocchiaro, Simona Frigerio
Publikováno v:
PLoS ONE, Vol 7, Iss 12, p e52301 (2012)
Immune-based treatments represent a promising new class of therapy designed to boost the immune system to specifically eradicate malignant cells. Immunotherapy may generate specific anti-tumor immune responses, and dendritic cells (DC), professional
Externí odkaz:
https://doaj.org/article/9a178412ea32421cb631861727bb261b
Autor:
Silvia Lanfranconi, Elisa Scola, Jennifer M T A Meessen, Roberto Pallini, Giulio A Bertani, Rustam Al-Shahi Salman, Elisabetta Dejana, Roberto Latini, Giorgia Abete Fornara, Nicolò M. Agnelli, Alessio Albanese, Issam Awad, Renzo Bagnati, Giovanna Balconi, Elena Ballabio, Ettore Beghi, Roberto Bernasconi, Giulio A. Bertani, Silvia Besana, Adriana Blanda, Chiara Bossi, Nereo Bresolin, Maria G. Buratti, Roberta Calabrese, Maria R. Carriero, Marco Castori, Elisa F. Ciceri, Rossella Ciurleo, Giacomo P. Comi, Valeria Contarino, Giorgio Conte, Leonardo D'Agruma, Giorgio Q. D'Alessandris, Ugo de Grazia, Rina Di Bonaventura, Piergiorgio d'Orio, Giuseppe Farago', Andreana Foresta, Carmela Fusco, Chiara Gaudino, Maria G. Lampugnani, Alessia Lanno, Francesca Lazzaroni, Cornelia Lee, Marco Locatelli, Aldo P. Maggioni, Peetra Magnusson, Matteo Malinverno, Maurizio Mangiavacchi, Antonella Mangraviti, Silvia Marino, Selene Mazzola, Enrico B. Nicolis, Deborah Novelli, Maria L. Ojeda Fernandez, Antonio Petracca, Fabrizio Pignotti, Simona Pogliani, Marco Poloni, Alessandro Prelle, Pamela Raggi, Franca Raucci, Caroline Regna-Gladin, Dario Ronchi, Emma Scelzo, Salim Seyfried, Anna Simeone, Carmelo L. Sturiale, Laura Tassi, Mauro Tettamanti, Valter Torri, Elisabeth Tournier-Lasserve, Rita Treglia, Fabio M. Triulzi, Celeste Ungaro, Elison Ursi, Gloria Valcamonica, Antonella Vasami', Barbara Zarino
Publikováno v:
2022, ' Safety and efficacy of propranolol for treatment of familial cerebral cavernous malformations (Treat_CCM) : a randomised, open-label, blinded-endpoint, phase 2 pilot trial ', Lancet Neurology, vol. 22, no. 1, pp. 35-44 . https://doi.org/10.1016/S1474-4422(22)00409-4
BACKGROUND: Observations in people with cerebral cavernous malformations, and in preclinical models of this disorder, suggest that the β-blocker propranolol might reduce the risk of intracerebral haemorrhage. We aimed to evaluate the safety and effi
Autor:
Laura Gatti, Luigi Rolli, Cristina Corno, Nives Carenini, Elisabetta Corna, Emilio Ciusani, Simona Frigerio, Simona Pogliani, Carmela Guarino, Ferdinando Ravagnani, Ugo Pastorino, Gabriella Sozzi, Alessandra Macciotta, Paolo Verderio, Chiara M. Ciniselli, Paola Perego
Publikováno v:
Translational Lung Cancer Research. 11:1315-1326
The secreted products of the metastasis suppressor geneKiSS1-derived peptide levels in liquid biopsies from 60 NSCLC patients were assayed by ELISA. Preclinical experiments were carried out using quantitative real time polymerase chain reaction (qRT-
Publikováno v:
Stem Cell Production ISBN: 9789811675881
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::103d0c704f5d0b3657b424fc236b492f
https://doi.org/10.1007/978-981-16-7589-8_6
https://doi.org/10.1007/978-981-16-7589-8_6
Autor:
Guido Maronati, Simona Frigerio, Simona Pogliani, Angela Marcianti, Francesco Petrella, Francesca Paino, Valentina Coccè, Loredana Cavicchini, Augusto Pessina, Eugenio Parati, Gianpietro Bondiolotti, Sara Nava, Daniela Lisini, Giulio Alessandri
Publikováno v:
Pharmaceutics
Volume 12
Issue 5
Pharmaceutics, Vol 12, Iss 411, p 411 (2020)
Volume 12
Issue 5
Pharmaceutics, Vol 12, Iss 411, p 411 (2020)
Mesenchymal stromal cells (MSCs) prepared as advanced therapies medicinal products (ATMPs) have been widely used for the treatment of different diseases. The latest developments concern the possibility to use MSCs as carrier of molecules, including c
Autor:
Gaetano Finocchiaro, Simona Pogliani, Simona Frigerio, Daniela Lisini, Sara Nava, Laura Gatti, Anna Bersano, Eugenio Parati, Serena Pellegatta
Publikováno v:
Pharmaceutics, Vol 12, Iss 3, p 215 (2020)
Pharmaceutics
Volume 12
Issue 3
Pharmaceutics
Volume 12
Issue 3
Dendritic cells (DC) are the most potent antigen-presenting cells, strongly inducers of T cell-mediated immune responses and, as such, broadly used as vaccine adjuvant in experimental clinical settings. DC are widely generated from human monocytes fo
Autor:
Sara, Nava, Daniela, Lisini, Simona, Frigerio, Simona, Pogliani, Serena, Pellegatta, Laura, Gatti, Gaetano, Finocchiaro, Anna, Bersano, Eugenio Agostino, Parati
Publikováno v:
Pharmaceutics
Dendritic cells (DC) are the most potent antigen-presenting cells, strongly inducers of T cell-mediated immune responses and, as such, broadly used as vaccine adjuvant in experimental clinical settings. DC are widely generated from human monocytes fo
Autor:
Simona Frigerio, Daniela Lisini, Gaetano Finocchiaro, Sara Nava, Anna Bersano, Simona Pogliani, Eugenio Parati, Marta Dossena, Serena Pellegatta
Publikováno v:
Stem cells translational medicine. 4(10)
Cell therapy based on dendritic cells (DCs) pulsed with tumor lysate is a promising approach in addition to conventional therapy for the treatment of patients with glioblastoma (GB). The success of this approach strongly depends on the ability to gen